Physician profile
Timothy Blankenship
NPI 1164440368
$2,140.53
in general payments reported to CMS, 2019-2025
19 companies · $646 in 2025
The $646 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $148 · 2021: $204 · 2022: $256 · 2023: $317 · 2024: $391 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343 · Education: $11.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.83 |
| Education | $11.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $521.31 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $386.09 | 2019-2025 | Hydrus Microstent, Precision 1, Tryptyr |
| Abbvie INC. | $282.51 | 2022-2025 | Lumigan, Alphagan P |
| Allergan, INC. | $246.26 | 2020-2021 | |
| Oyster Point Pharma, INC. | $104.61 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $97.14 | 2019-2023 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $96.50 | 2021-2025 | Cequa |
| Coopervision INC. | $74.50 | 2022-2025 | Misight Contact Lens, Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $63.00 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $57.20 | 2023-2025 | Iheezo, Vevye |
| Horizon Therapeutics Plc | $33.32 | 2023 | Tepezza |
| Thea Pharma INC. | $33.14 | 2023 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $30.65 | 2019-2025 | |
| Dompe US, INC. | $25.90 | 2024 | Oxervate |
| Biotissue Holdings INC. | $22.94 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $19.41 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.78 | 2020 | |
| Shire North American Group INC | $16.81 | 2019 | |
| Menicon America INC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.